# Drug-Disease Interaction in Crohn's Disease

> **NCT01261286** · PHASE1 · COMPLETED · sponsor: **University of Alberta**

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** verapamil

## Key facts

- **NCT ID:** NCT01261286
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261286, "Drug-Disease Interaction in Crohn's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01261286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*